Trevi Therapeutics, Inc. (TRVI)
11.58
-0.35
(-2.93%)
USD |
NASDAQ |
Apr 01, 16:00
11.60
+0.02
(+0.17%)
After-Hours: 20:00
Trevi Therapeutics Total Assets (Quarterly) : 193.62M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Puma Biotechnology, Inc. | 217.67M |
| Bristol Myers Squibb Co. | 90.04B |
| Terns Pharmaceuticals, Inc. | 1.025B |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.38M |
| Shareholders Equity (Quarterly) | 183.24M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 19.66 |
| Net Debt Paydown Yield | 0.00% |